Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study. [PDF]
TrialsTaniguchi F +4 more
europepmc +1 more source
Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study. [PDF]
Sci RepMuzii L +9 more
europepmc +1 more source
New Chemo-, Regio- and Stereoselective Reactions and Methods in Organic Synthesis. [PDF]
Int J Mol SciMusalov MV.
europepmc +1 more source
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study. [PDF]
Sci RepMajidova N +37 more
europepmc +1 more source
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation. [PDF]
J Gastrointest CancerUeberroth BE, Lieu CH, Lentz RW.
europepmc +1 more source
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations. [PDF]
Clin Lung CancerLara MS +5 more
europepmc +1 more source
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma. [PDF]
OncologistWeber J +16 more
europepmc +1 more source
Satisfaction and persistence with vibegron in the first 6 months of overactive bladder treatment: interim results of the phase 4, real-world COMPOSUR study. [PDF]
BMC UrolDmochowski RR +7 more
europepmc +1 more source